Search USGSSearch

USGS · 70030870

Detection of group 1 coronaviruses in bats in North America

Abstract

The epidemic of severe acute respiratory syndrome (SARS) was caused by a newly emerged coronavirus (SARS-CoV). Bats of several species in southern People's Republic of China harbor SARS-like CoVs and may be reservoir hosts for them. To determine whether bats in North America also harbor coronaviruses, we used reverse transcription-PCR to detect coronavirus RNA in bats. We found coronavirus RNA in 6 of 28 fecal specimens from bats of 2 of 7 species tested. The prevalence of viral RNA shedding was high: 17% in Eptesicus fuscus and 50% in Myotis occultus. Sequence analysis of a 440-bp amplicon in gene 1b showed that these Rocky Mountain bat coronaviruses formed 3 clusters in phylogenetic group 1 that were distinct from group 1 coronaviruses of Asian bats. Because of the potential for bat coronaviruses to cause disease in humans and animals, further surveillance and characterization of bat coronaviruses in North America are needed.

Explore related subjects

90° N90° S · 180° W ← longitude → 180° E
Source-reported bounding extent: 15.623036831528264° to 78.27820145542813° latitude; -169.8046875° to -51.67968749999999° longitude. This indicates report coverage, not an exact sampling location. View area on OpenStreetMap.

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S.R. Dominguez, T. J. O'Shea, L.M. Oko, K.V. Holmes. 2007. Detection of group 1 coronaviruses in bats in North America. https://doi.org/10.3201/eid1309.070491

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related USGS reports

Mortality event in rainbow snakes linked to snake fungal disease, United States

We report mortality in rainbow snakes in Virginia and North Carolina, USA, linked to snake fungal disease caused by Ophidiomyces ophidiicola . During 2013–2023, we observed 46 dead rainbow snakes with lesions indicative of snake fungal disease, noted elevated disease severity compared with other species, and recorded fewer live snakes over time.

North Carolina, Virginia

Safety and immunogenicity of poultry vaccine for protecting critically endangered avian species against highly pathogenic avian influenza virus, United States

In 2023, an outbreak of highly pathogenic avian influenza occurred among critically endangered California condors ( Gymnogyps californianus ), and > 21 died. We evaluated safety, immunogenicity, vaccination strategies, and correlates of antibody response of an influenza vaccine for poultry in black vultures ( Coragyps atratus ) and then California condors. We noted differences in antibody titers between vaccinated and unvaccinated birds (vultures p < 0.004; condors p­ < 0.02) but no adverse effects of vaccination. All vaccinated vultures and 80% of vaccinated condors showed maximum measured antibody response within the published range associated with survival of vaccinated and virally challenged chickens. We noted weak evidence of higher antibody responses for birds given two 0.5-mL vaccines versus those given one 1-mL vaccine but no correlation between antibody titers and sex for either species or between antibody titers and bone lead concentrations in vultures. Our results prompted initiation of a vaccination program for condors that could reduce spread of this disease among highly threatened species.

Emerging Infectious Diseases

Exposure of wild mammals inhabiting Alaska to influenza A(H5N1) virus

Serum samples from wild mammals inhabiting Alaska, USA, showed that 4 species, including Ursus arctos bears and Vulpes vulpes foxes, were exposed to influenza A(H5N1) viruses. Results indicated some mammals in Alaska survived H5N1 virus infection. Surveillance efforts may be improved by incorporating information on susceptibility and detectable immune responses among wild mammals.

Alaska